Zrc Wealth Management, LLC Terns Pharmaceuticals, Inc. Transaction History
Zrc Wealth Management, LLC
- $211 Billion
- Q2 2024
A detailed history of Zrc Wealth Management, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Zrc Wealth Management, LLC holds 265 shares of TERN stock, worth $2,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265
Previous 225
17.78%
Holding current value
$2,247
Previous $1.48 Million
22.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TERN
# of Institutions
121Shares Held
61.3MCall Options Held
155KPut Options Held
48.3K-
Orbimed Advisors LLC San Diego, CA7.62MShares$64.6 Million1.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.66MShares$56.5 Million5.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$51.7 Million1.32% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.43MShares$29.1 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY3.41MShares$28.9 Million1.92% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $319M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...